Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-26

Clinical Trial Update: Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of using nevirapine together with rifampicin in patients co-infected with HIV and tuberculosis; the study is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)
  • Rifampicin

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: HIV/TB Co-infection | Phase 3 | Status: COMPLETED